Tag: Stimulant shortage

Since 2022, patients with ADHD have experienced a persistent, nationwide shortage of stimulant medications, including Adderall, Vyvanse, and other generics. While Dexedrine (dextroamphetamine) is sometimes in short supply, it has historically been impacted less often than Adderall, though it is not immune to the broader market fluctuations. Navigating these shortages requires strategic communication with healthcare providers and pharmacists to ensure continuity of care.

ADHD medication shortages have become an unfortunate reality for many, with supply chain issues and increased demand contributing significantly to the problem. This guide provides a clear and proactive plan for **what to do when ADHD meds are out of stock** to minimize treatment disruption.